BOD Science Ltd (BOD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.175x

Based on the latest financial reports, BOD Science Ltd (BOD) has a cash flow conversion efficiency ratio of -0.175x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$900.22K ≈ $636.96K USD) by net assets (AU$-5.15 Million ≈ $-3.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

BOD Science Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how BOD Science Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BOD Science Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

BOD Science Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BOD Science Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Norcros Plc
LSE:NXR
0.069x
Parkd Ltd
AU:PKD
-9.779x
Zeb Nickel Corp
V:ZBNI
0.000x
Novra Technologies Inc
V:NVI
-0.231x
FiscalNote Holdings Inc.
NYSE:NOTE
-0.110x
Datadot Technology Ltd
AU:DDT
-0.008x
Svenska Aerogel Holding AB (publ)
ST:AERO
-0.153x
INTL SCHOOL AUGS.AG NA ON
F:9JK
N/A

Annual Cash Flow Conversion Efficiency for BOD Science Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of BOD Science Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see how much is BOD Science Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-5.15 Million
≈ $-3.65 Million
AU$937.08K
≈ $663.04K
-0.182x -205.79%
2024-06-30 AU$-5.32 Million
≈ $-3.76 Million
AU$-913.98K
≈ $-646.70K
0.172x -97.87%
2023-06-30 AU$-703.36K
≈ $-497.67K
AU$-5.68 Million
≈ $-4.02 Million
8.072x +770.07%
2022-06-30 AU$3.47 Million
≈ $2.45 Million
AU$-4.18 Million
≈ $-2.96 Million
-1.205x -78.87%
2021-06-30 AU$8.66 Million
≈ $6.13 Million
AU$-5.83 Million
≈ $-4.13 Million
-0.674x -0.44%
2020-06-30 AU$4.81 Million
≈ $3.40 Million
AU$-3.22 Million
≈ $-2.28 Million
-0.671x +78.63%
2019-06-30 AU$2.07 Million
≈ $1.46 Million
AU$-6.48 Million
≈ $-4.59 Million
-3.137x -177.39%
2018-06-30 AU$2.62 Million
≈ $1.85 Million
AU$-2.96 Million
≈ $-2.10 Million
-1.131x -43.54%
2017-06-30 AU$3.00 Million
≈ $2.12 Million
AU$-2.36 Million
≈ $-1.67 Million
-0.788x -1925.02%
2016-06-30 AU$5.52 Million
≈ $3.91 Million
AU$-214.91K
≈ $-152.07K
-0.039x --

About BOD Science Ltd

AU:BOD Australia Drug Manufacturers - Specialty & Generic
Market Cap
$3.01 Million
AU$4.26 Million AUD
Market Cap Rank
#29195 Global
#1701 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.02
All Time High
AU$0.67
About

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and dis… Read more